Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...

IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how understand, diagnose, and treat disease, and Waters Corporation, a global leader in life sciences ...

The following article is an opinion piece written by Rosa Sottile, PhD. The views and opinions expressed in this article are those of the author and do not necessarily reflect the official position of ...

Flow cytometry continues to evolve, yet many experiments are still limited by avoidable issues in panel design, control selection, reagent handling, and instrument understanding. As analytical ...

This technology has vast potential to help patients but remains underutilized and underappreciated. The tools are there. What’s lacking are harmonized controls, regulatory guidelines and database ...